share

N1-[3-[[3-(Cyclohexylamino)Propyl]Amino]Propyl]-7,8-Dihydrobleomycinamide CAS NO 52198-95-5


Unit Price:

CAS No.:52198-95-5

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

N1-[3-[[3-(Cyclohexylamino)Propyl]Amino]Propyl]-7,8-Dihydrobleomycinamide is a chemically modified derivative of the bleomycin family of glycopeptide antibiotics, designed for enhanced research and development applications. This compound is valued for its potential in biochemical research, particularly in studies related to DNA interaction and as a key intermediate for the synthesis of novel therapeutic agents. It is primarily sought by pharmaceutical R&D laboratories, academic research institutions, and fine chemical manufacturers focused on oncology and molecular biology.

Application

  • Pharmaceutical Research & Development: Serves as a critical intermediate in the synthesis of novel bleomycin analogs for preclinical studies.
  • Biochemical Studies: Used as a tool compound to investigate mechanisms of DNA cleavage and interaction in vitro.
  • Oncology Research: Explored for its potential antitumor properties and structure-activity relationship (SAR) studies.
  • Academic Research: Employed in university and institutional labs for fundamental research in biochemistry and medicinal chemistry.
  • Fine Chemical Synthesis: Acts as a specialized building block for the custom synthesis of complex glycopeptide derivatives.
  • Reference Standard: Can be utilized as a high-purity analytical standard for method development and quality control in related compound analysis.

Basic Information

Product Name N1-[3-[[3-(Cyclohexylamino)Propyl]Amino]Propyl]-7,8-Dihydrobleomycinamide
CAS No. 52198-95-5
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms 7,8-Dihydrobleomycinamide, N1-[3-[[3-(Cyclohexylamino)propyl]amino]propyl]-; Bleomycin derivative; BLM derivative; N1-(3-((3-(Cyclohexylamino)propyl)amino)propyl)-7,8-dihydrobleomycinamide; Modified bleomycin; Cyclohexylamino-propyl bleomycinamide
EINECS Contact for details

Quality Control

Our N1-[3-[[3-(Cyclohexylamino)Propyl]Amino]Propyl]-7,8-Dihydrobleomycinamide is produced under strict quality management protocols to ensure batch-to-batch consistency and high purity suitable for research applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to relevant industry standards for fine chemicals and research materials, ensuring reliable performance in your critical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept under dry conditions to prevent degradation. For long-term storage, consider desiccants or an inert atmosphere.

Specification

Item Specification
Appearance White to off-white powder
Identification (HPLC/MS) Conforms
Purity (HPLC) ≥ 95.0%
Water Content (KF) ≤ 5.0%
Residual Solvents (GC) Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.